| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2025 | Mar 20, 2025 | Swirsky Douglas J CFO | Sell | Maxcyte, Inc. | MXCT | $3.18 | $22,061 | -5.84% |
| Sep 14, 2021 | Sep 14, 2021 | Swirsky Douglas J Dir | Buy | Cellectar Biosciences, Inc. | CLRB | $1.04 | $26,000 | +50.00% |
| Jan 29, 2019 | Jan 30, 2019 | Swirsky Douglas J Pres CEO | Buy | Rexahn Pharmaceuticals, Inc. | RNN | $0.63 | $31,720 | +50.00% |
| Sep 16, 2016 | Sep 16, 2016 | Swirsky Douglas J Pres CEO | Buy | Genvec Inc | GNVC | $0.5 | $5,000 | +3.81% |
| Dec 14, 2015 | Dec 15, 2015 | Swirsky Douglas J Pres CEO | Buy | Genvec Inc | GNVC | $2 | $10,000 | +2.02% |
| Dec 15, 2014 | Aug 07, 2015 | Swirsky Douglas J Pres CEO | Buy | Genvec Inc | GNVC | $1.9 | $10,450 | +2.26% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.